Factors that influence serum hyaluronan levels in hemodialysis patients

ASAIO Journal

Volumn 45, Issue 5, 1999, Pages 428-430

  De Medina, Maria ^a   Ashby, Melanie ^a   Diego, Jorge ^a   Philip Pennell, J ^a   Hill, Mary ^a   Schiff, Eugene R ^b   Perez, Guido O ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMYLOID A PROTEIN; C REACTIVE PROTEIN; FERRITIN; HYALURONIC ACID; SERUM ALBUMIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC INFLAMMATION; FEMALE; FERRITIN BLOOD LEVEL; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS C; HUMAN; INFECTION; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; RHEUMATOID ARTHRITIS; SERUM;

EID: 0033200872     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199909000-00012     Document Type: Article

References (12)

1. Henderson L, Koch K, Dinarello C, Shaldon S: Hemodialysis hypotension: interleukin hypothesis. Blood Purif 1: 328, 1983.
2. Turney JH, Davison AM, Forbes MA, Cooper EH: Hyaluronic acid in end-stage renal failure treated by haemodialysis: clinical correlates and implications. Nephrol Dial Transplant 6: 566-570, 1991.
3. Honkanen E, Froseth B, Gronhagen-Riska C: Serum hyaluronic acid and procollagen 111 amino terminal propeptide in chronic renal failure. Am J Nephrol 11: 201-206, 1991.
4. Lipkin GW, Forbes MA, Cooper EH, Turney JH: Hyaluronic acid metabolism and its clinical significance in patients treated by continuous ambulatory peritoneal dialysis. Nephrol Dial Transplants: 337-360, 1993.
5. Hallgren R, Engstrom-Laurent A, Nisbeth U: Circulating hyaluronate. A potential marker of altered metabolism of the connective tissue in uraemia. Nephron 46: 150-154, 1987.
6. Woodrow G, Turney JH, Davison AM, Cooper EH: Serum hyaluronan concentrations predict survival in patients with chronic renal failure on maintenance haemodialysis. Nephrol Dial Transplant 11:98-100, 1996.
7. Kaysen GA, Frazier T, Stevenson, Depner TA: Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis 29: 658-668, 1997.
8. Engstrom-Laurent A, Loof L, Nyberg A, Schroder T: Increased serum levels of hyaluronate in liver disease. Hepatology 4: 638-642, 1985.
9. Takasu S, Takatsu S, Kunitomo K, Kokumai Y: Serum hyaluronic acid and interleukin-6 as possible markers of carpal tunnel syndrome in chronic hemodialysis patients. Artif Organs 18: 420-424, 1994.
10. Ozasa H, Chichibu K, Tanaka Y, Kondo T, Kitajima K, Ota K: Relationship between plasma levels of hyaluronic acid and amyloid-associated osteoarthropathy in chronic hemodialysis patients. Nephron 61: 187-191, 1992.
11. Cooper EH, Rathbone J: Clinical significance of the immunometric measurements of hyaluronic acid. Ann Rheum Dis 44: 83-88, 1985.
12. Lowrie EG, Lew ML: Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15: 458-482, 1990.